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Abstract: We conducted a retrospective mortality study in an Inner Mongolian village ex-
posed to well water contaminated by arsenic since the 1980s. Deaths occurring between
January 1, 1997 and December 1, 2004 were classiﬁed according to underlying cause and
water samples from household wells were tested for total arsenic. Heart disease mortality
was associated with arsenic exposure, and the association strengthened with time exposed to
the water source. Cancer mortality and all-cause mortality were associated with well-water
arsenic exposure among those exposed 10-20 years. This is the ﬁrst study to document in-
creased arsenic-associated mortality in the Bayingnormen region of Inner Mongolia.
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1. Introduction
Worldwide, millions of people are at risk from the adverse effects of arsenic exposure through drink-
ing water. Studies in Taiwan, Argentina, the United States and Chile have documented increased bladder,
lung and skin cancer mortality as a result of arsenic exposure [1, 2, 3]. Chronic arsenic exposure has also
been associated with non-cancer health effects including vascular and cardiovascular effects, diabetes,
peripheral neuropathies, and adverse birth outcomes [4, 5, 6, 7, 8].
The Bayingnormen (Ba Men) region located on the Hetao Plain, north of the Huang He (Yellow)
River in western Inner Mongolia, China, is affected by chronic arsenic exposure from contaminated well
water especially in the three counties of Hangjin Hou, Lin He and Wu Yuan. In the late 1970s, the
primary source of drinking water shifted away from large shallow wells to deeper artesian wells, which
were often contaminated by naturally occurring arsenic. Characteristic arsenic-induced skin lesions were
reported in the region in the early 1990s [9].
Ba Men is a rich agricultural region and most residents of the region are farmers. Most households
receive their water from a hand pump well located adjacent to the household compound. Because of a
lack of access to other types of water this well is their primary source of water for drinking, cooking,
bathing and other household uses. Well water appears to be the primary source of arsenic exposure in the
Ba Men region. Ma [9] reported that drinking water was the only signiﬁcant source of arsenic exposure,
that arsenic containing pesticides had not been used, and that samples from soil, food and surface water
met or were lower than China national standards.
Several studies have documented the prevalence of arsenicosis as well as other adverse health effects
associated with arsenic exposure from this region [9, 10, 11, 12, 13]. However, few systematic investi-
gations of excess mortality have been conducted. We conducted a retrospective mortality study of one
arsenic-exposed village in the Ba Men region, Shahai village, located in Hangjin Hou. While we recog-
nized that the number of deaths from this relatively small village (approximately 12,000 residents) would
not be enough to examine cause-speciﬁc mortality for speciﬁc conditions (for example, bladder cancer
mortality) in relation to arsenic exposure, we anticipated sufﬁcient cases to evaluate broader causes of
mortality such as all-cancer mortality, and heart disease mortality. Our speciﬁc goals were to:
1) Identify deaths that occurred in the village between January 1, 1997 and December 1, 2004 and
classify each according to underlying cause of death;
2) Evaluate the relationship between mortality rate and arsenic exposure from the primary water
source.
2. Methods
2.1. Census and Mortality Classiﬁcation
Cause of death is not systematically recorded in Ba Men. To classify causes of death, we conducted
a complete census of the village. Each family provided names and demographic characteristics of all
family members residing in the household between January 1, 1997 and December 1, 2004, including
those who moved away and those who died.
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and the Ba Men Anti Epidemic Station visited each family in the village and interviewed an adult house-
hold member during November and December 2004. Two interviewers visited each household, and at
least one was a medical professional (nurse or physician). The interview consisted of a census of house-
hold members (including those who had moved), health and mortality assessments. The interviews
included questions about demographic characteristics for each person living in the household since Jan-
uary 1, 1997, including date of birth, sex, ethnicity, occupation, smoking habits (current smoker, quit,
and years smoked) alcohol use (every day, sometimes or never) and a detailed residence history. The
residence history consisted of a description of the water source (hand pump well, large mouth well,
community well, or other), and the dates and location of the residence for each family member for the
past 30 years.
We obtained information about each death occurring in the household since January 1, 1997. The de-
ceased’s closest living relative provided a description of the conditions surrounding the death, and details
about any health conditions afﬂicting the deceased. This verbal description was recorded to accurately
preserve the description for cause of death classiﬁcation. All medical records relating to the deceased
including doctor’s notes, diagnoses, and medication information were collected. Study personnel also
obtained the names and locations of any physicians, hospitals or clinics visited by the deceased. These
physicians and clinics were contacted, additional existing medical records were obtained, and whenever
possible, the attending physician was interviewed. A team of medical experts including a pathologist,
a nosologist with training in the International Classiﬁcation of Diseases, 10th Revision (ICD-10) [14],
and a medical epidemiologist evaluated the evidence available and coded each underlying cause of death
according to the ICD-10 system. When additional expertise was required for classiﬁcation, specialists
in other medical ﬁelds were consulted. The medical team was unaware of and blinded to the arsenic
exposure levels from the water source. For analysis and description, we grouped ICD-10 codes accord-
ing to the 113 leading causes of mortality deﬁned by the National Center for Health Statistics [15]. The
number deaths occurring in the village during the period were conﬁrmed with local health ofﬁcials.
Research staff at the Ba Men Anti-Epidemic Station double-entered all data in a MS Access database,
pre-programmed with logic checks and restricted entry to reduce data entry errors. Discrepancies were
identiﬁed and corrected by referring to the original survey form and if necessary, contacting the respon-
dent for additional information and clariﬁcation.
2.2. Water Collection and Arsenic Analysis
At the time of interview, we collected approximately 40 ml of water in 50 ml polypropylene test
tubes at the household’s primary source of water. We previously tested the collection tubes washing
them with water containing acid (nitric acid) and tested them for arsenic concentrations, which were
below detection limit. During arsenic analysis of the samples, we also included the negative controls
using the same type of tube containing known arsenic-free water. The arsenic concentrations in these
negative controls were below detection limit. After collection, the samples were stored at -20◦C and then
delivered on ice via air to University of Alberta in Edmonton, Canada for analysis. We measured total
arsenic in water samples using inductively coupled plasma mass spectrometry (ICPMS) as described
previously [13, 16]. The detection limit for ICPMS is 0.1 µg/L. For some households (N=141), water
samples were analyzed by the IMCEDCR using Atomic Fluorescence (AF, detection limit=0.4 µg/L).Int. J. Environ. Res. Public Health 2009, 6 1110
We assigned arsenic exposures based on the measured arsenic value from the resident’s well, shared
well, or community well. For those results below the detection limit, we assigned one-half the detection
limit as the exposure value.
2.3. Statistical Methods
Based on estimates of mortality rates and the size of the village, we initially calculated 80% power to
observe an Incidence Rate Ratio (IRR) of 2 for a 50 µg/L increase in arsenic exposure for heart disease
mortality, andbetween70%and80%statisticalpowerfortotalcancerandcerbrovasculardisease(stroke)
mortality.
We used Poisson regression to model mortality rates and to estimate the Incidence Rate Ratio (IRR)
as a function of person-years of arsenic exposure. To account for the potential time-lag between arsenic
exposure and observed population mortality rate, we restricted the analysis to those who had been ex-
posed at the same water source since 2000 (approximately 5 years), 1995 (approximately 10 years), 1990
(approximately 15 years) and 1985 (approximately 20 years).
We controlled for age in years (continuous), sex (male versus female), education level (coded as an
ordinal variable, 1 through 5, ranging from incomplete primary school through college degree) current
smoking status (smoker versus non-smoker), and current alcohol consumption (yes or no). These covari-
ates were considered for multivariate models based on their marginal association with arsenic, or their
known or suspected association with the causes of mortality under study. We compared the change in
the arsenic coefﬁcient from the fully adjusted models, to models adjusting for just age and sex (reduced
model), and an unadjusted model. Because the fully adjusted model usually indicated at least some con-
founding (based on a change in the arsenic coefﬁcient), we reported results of the fully adjusted models.
In these models, arsenic was the primary exposure of interest and was modeled as a continuous vari-
able. We also evaluated arsenic effects by grouping exposures into ﬁve arsenic categories: 0-5, 5.1-20,
20.1-100, 100.1-300, and greater than 300 µg/L and created corresponding indicator variables. For com-
parison purposes, we calculated age-adjusted mortality rates with direct standardization [17], using the
United States Standard Population from 2000 [15].
All regression models used robust standard error calculations to correct for the clustered household
sample [18]. We used Stata 9.2 for all statistical analysis [19].
3. Results
3.1. Mortality
A total of 572 incident deaths were identiﬁed in the period between January 1, 1997 and December
1, 2004. Characteristics of the deceased residents are shown in Table 1. The mean age of death was 66
years of age. Deceased women were older than deceased men at the time of death (68 years of age vs. 64
years of age, p=0.03). Leading causes of death are summarized in Figure 1. Diseases of the heart were
the leading causes of mortality, accounting for 206, or 36% of the 572 deaths. Of these, 87 were due to
acute myocardial infarction or cardiac arrest. Cerebrovascular diseases, including stroke, were the next
most frequently reported cause of death making up 25% of the deaths, followed by malignant neoplasms
(13%), suicide (4%), and accidents (3%). Lung cancer was the most frequent type of cancer, causing 19Int. J. Environ. Res. Public Health 2009, 6 1111
deaths, followed by stomach cancer (11 deaths). Cause of death could not be classiﬁed for ﬁve deaths.
Forty deaths classiﬁed as ”Other” occurred fewer than four times and included causes classiﬁed as: legal
intervention, homicide, septicemia, trauma, poisoning and diabetes.
Table 1. Characteristics of 572 deceased residents of Shahai village, Inner Mongolia.
No. %
Sex
Male 327 57.2%
Female 245 42.8%
Total 572 100.0%
Age category
0-5 6 1.1%
6-10 5 0.9%
11-15 1 0.2%
16-20 6 1.1%
21-30 11 1.9%
31-40 14 2.5%
41-50 34 6.0%
51-60 66 11.6%
61-70 144 25.3%
71-80 191 33.5%
Over 80 92 16.1%
Total 570 100.0%
Race/Ethnicity
Han 571 99.8%
Mongol 1 0.2%
Total 572 100.0%
Occupation
Agriculture 498 89.6%
Industry 2 0.4%
Professional 6 1.1%
Teacher 7 1.3%
Student 6 1.1%
Service 2 0.4%
Not employed 24 4.3%
Other 11 2.0%
Total 556 100.0%Int. J. Environ. Res. Public Health 2009, 6 1112
Table 1. Cont.
Smoking
Current smoker 261 46.4%
Ex-smoker 63 11.2%
Never smoked 239 42.5%
Total 563 100.0%
Education
College 1 0.2%
High school 17 3.0%
Middle school 60 10.5%
Primary school 81 14.2%
Some primary or none 410 72.1%
Total 569 100.0%
Household income (Yuan)
0-999 30 5.2%
1000-9999 391 68.4%
10000 or more 151 26.4%
Total 572 100.0%
Alcohol drinking
Never drinker 381 67.8%
Ever drinker 181 32.2%
Total 562 100.0%
Years exposed to current water source
Under 1 2 0.4%
1-10 247 43.4%
11-20 262 46.0%
21-30 58 10.2%
Total 569 100.0%
Well water arsenic (µg/L)
0-5 176 31.3%
5.1-20 102 18.1%
20.1-100 234 41.6%
100.1-300 42 7.5%
Over 300 8 1.4%
Total 562 100.0%Int. J. Environ. Res. Public Health 2009, 6 1113
Table 1. Cont.
Well source
Community well or other 145 25.5%
Hand pump well 424 74.5%
Total 569 100.0%
Figure 1. Leading causes of mortality among residents of Shahai Village, Inner Mongolia.
Residents contributed a total of 78,251 person-years of time since January 1, 1997, with a mean of
6.1 person-years. The crude mortality rate was 731 deaths per 100,000 person years, 814 per 100 000
person-years among men and 646 per 100,000 person years among women. The age-adjusted mortality
rates were 1096 per 100,000 person-years among all residents, and 1203 and 946 per 100,000 person
years among males and females, respectively. For comparison, the 2003 age-adjusted mortality rate of
the United States population was 831.2 among all subjects, and 991.7 and 705.4 per 100,000 among
males and females respectively. Using the World Health Organization standard population for direct
adjustment [20], the age-adjusted mortality rate in Shahai village for this time period was 720.6 per
100 000 person-years compared to 842.5 per 100 000 for the 2002 China population [21]. This lower
mortality rate may reﬂect the generally good health status of the population region which has been noted
previously [13, 22].Int. J. Environ. Res. Public Health 2009, 6 1114
3.2. Arsenic Exposure
Among both living and deceased residents, total arsenic in water samples from current primary source
of water ranged from below detection to 637.7 µg/L, with mean exposure of 38.0 µg/L (median 21 µg/L).
Arsenic exposures among deceased residents are summarized in Table 1. Arsenic exposures for a total
of 52 households (included 10 deceased) could not be assigned due to either an unavailable or damaged
water sample, or because the deceased moved out of the village prior to death. An additional 141
households were assignedarsenic values usingdata provided by theIMCEDCR.A total of65 households
had results for water arsenic below the detection limit (46 with the ICPMS method and 19 from the AF
method) and were assigned arsenic exposures one-half the detection limit. Fifty of the 562 deceased
residents for whom arsenic exposures were available (9%) were exposed to well water arsenic above
100 µg/L and nearly three quarters used a hand-pump well for their primary source of water (Table 1).
Among both deceased and living subjects, residents reported using their current water source a mean of
9.9 years, with deceased residents using their current water source an average of 11.6 years.
3.3. Mortality and Arsenic Exposure
Results from multivariate Poisson regression models summarizing the effect of a 50 µg/L increase in
arsenic on all-cause mortality, heart disease mortality, all-cancer mortality and cerebrovascular disease
mortality are summarized in Table 2.
Among all residents, there was a signiﬁcant association between heart disease mortality and arsenic
exposure. A 50 µg/L increase in arsenic was associated with a 12% increase in heart disease mortality
(IRR=1.12, p=0.03). The risk of heart disease mortality increased as time exposed to the water source
increased. Among residents exposed to the same well since before 2000, a 50 µg/L increase in arsenic
exposure was associated with a 16% increase heart disease mortality rate. The association peaked among
residentsexposedsincebefore1990. Amongtheseresidents, a50µg/Lincreaseinarsenicwasassociated
with a 24% increase in heart disease mortality rate.
Although there were fewer cancer deaths, there was also some evidence of an association between
arsenic exposure and total cancer mortality. A signiﬁcant trend was evident among residents exposed
since before 1995 (IRR=1.18, p=0.048), and was slightly stronger among residents exposed since before
1995 and 1990 (Table 2).
A 50 µg/L increase in arsenic exposure was also associated with a 12% and 15% increase in all-cause
mortality among residents exposed since before 1990 and 1985, respectively (Table 2).
Crude mortality rates and adjusted IRRs for residents exposed since before 1990 and since before
1995 are shown in Table 3 and Table 4. Although there were few deaths due to cancer above 300
µg/L, heart disease mortality rates increased across categories of arsenic exposure and both cancer and
all cause mortality peaked in the most highly exposed groups. In the categorical analysis, a decreased
mortality due to stroke was observed for those exposed under 100 µg/L since 1995 (Table 4). However,
this effect was not observed among those exposed since 1990 (Table 3) and was also not supported in
the continuous analysis presented in Table 2 where no trend was evident.Int. J. Environ. Res. Public Health 2009, 6 1115
Table 2. Adjusted incidence rate ratios for mortality between January 1, 1997 and December
1, 2004 and arsenic exposure for all residents of Shahai village, and residents exposed to the
same water source before 2000, 1995, 1990 and 1985.
All subjects
All-cause mortality Heart disease mortality Cancer mortality Stroke mortality
IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p
Arsenic
50 µg/L increase 1.02 1.12* 1.07 0.82
0.94,1.11 1.01,1.23 0.89,1.28 0.65,1.03
0.616 0.034 0.464 0.086
Number 12600 12600 12600 12600
Exposed since before 2000
All-cause mortality Heart disease mortality Cancer mortality Stroke mortality
IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p
Arsenic
50 µg/L increase 1.04 1.13* 1.09 0.82
0.95,1.13 1.02,1.26 0.92,1.30 0.64,1.05
0.394 0.016 0.305 0.109
Number 8967 8967 8967 8967
Exposed since before 1995
All-cause mortality Heart disease mortality Cancer mortality Stroke mortality
IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p
Arsenic
50 µg/L increase 1.09 1.19** 1.18* 0.86
0.99,1.19 1.05,1.33 1.00,1.40 0.67,1.12
0.084 0.005 0.048 0.266
Number 6394 6394 6394 6394
Exposed since before 1990
All-cause mortality Heart disease mortality Cancer mortality Stroke mortality
IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p
Arsenic
50 µg/L increase 1.12* 1.24*** 1.20 0.88
1.01,1.23 1.10,1.41 1.00,1.44 .68,1.15
0.027 0.001 0.056 0.356
Number 3213 3213 3213 3213
Exposed since before 1985
All-cause mortality Heart disease mortality Cancer mortality Stroke mortality
IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p
Arsenic
50 µg/L increase 1.15** 1.22* 1.22* 0.98
1.03,1.27 1.03,1.44 1.03,1.45 0.76,1.26
0.009 0.021 0.023 0.866
Number 1775 1775 1775 1775
1: Incidence rate ratio adjusted for age, sex, education, smoking, drinking, and farm work
* p<0.05, ** p<0.01, *** p<0.001Int. J. Environ. Res. Public Health 2009, 6 1116
Table 3. Crude death rates by arsenic exposure category among residents exposed since
before 1990.
Arsenic (µg/L) All deaths Rate (per 100,000) Adjusted IRR1 95% CI p
0-5 115 1218.05 ref ref ref
5.1-20 49 985.49 0.87 0.62-1.22 0.413
20.1-100 86 1181.58 0.92 0.70-1.22 0.573
100.1-300 31 1459.02 1.05 0.71-1.54 0.815
Over 300 6 3599.29 3.39 1.32-8.69 0.011
Arsenic (µg/L) Heart disease Rate (per 100,000) Adjusted IRR1 95% CI p
0-5 36 381.3 ref ref ref
5.1-20 12 241.35 0.75 0.37-1.51 0.418
20.1-100 37 508.36 1.28 0.79-2.07 0.315
100.1-300 15 705.98 1.60 0.87-2.95 0.132
Over 300 2 1199.77 5.08 1.45-17.81 0.011
Arsenic (µg/L) Cancer Rate (per 100,000) Adjusted IRR1 95% CI p
0-5 11 116.51 ref ref ref
5.1-20 11 221.23 2.11 0.92-4.85 0.078
20.1-100 12 164.87 1.40 0.60-3.26 0.438
100.1-300 4 188.26 1.42 0.45-4.46 0.545
Over 300 1 599.89 6.25 1.08-36.22 0.041
Arsenic (µg/L) Stroke Rate (per 100,000) Adjusted IRR1 95% CI p
0-5 40 423.67 ref ref ref
5.1-20 13 261.46 0.62 0.33-1.18 0.147
20.1-100 20 274.79 0.65 0.38-1.12 0.118
100.1-300 6 282.39 0.58 0.26-1.29 0.181
Over 300 1 599.88 1.64 0.31-8.77 0.565
1: Incidence rate ratio adjusted for age, sex education, smoking, alcohol use, farm work
3.4. Other Factors Associated with Mortality
The relationship between mortality rates and demographic and health characteristics among all res-
idents are shown in Table 5. Lower education level was associated with increased mortality with a
27.5% increase in mortality rate with each lower completed education level. Heart disease mortality
was strongly associated with farm work (IRR=3.31, p<0.001). Cancer mortality was strongly associated
with smoking (IRR=2.47, p<0.001) and lower education level (IRR=1.76, p<0.001).
4. Discussion
Despiterelativelymoderatearsenicexposures, weobservedanassociationbetweenwell-waterarsenic
exposure and heart disease mortality, cancer mortality, and all-cause mortality for the approximately
eightyearperiodfromJanuary1, 1997throughDecember1, 2004. Theeffectofarseniconmortalitywas
morepronouncedamongthoseexposedforlongerperiodsoftime, probablyreﬂectingalagtimebetween
exposure and observable effects on population mortality. The observation of an association between
heart disease mortality and arsenic exposure among all residents at their current water source withoutInt. J. Environ. Res. Public Health 2009, 6 1117
Table 4. Crude death rates by arsenic exposure category among residents exposed since
before 1995.
Arsenic (µg/L) All deaths Rate (per 100,000) Adjusted IRR1 95% CI p
0-5 146 997.55 ref ref ref
5.1-20 79 873.26 0.89 0.68-1.17 0.401
20.1-100 179 837.75 0.84 0.68-1.06 0.139
100.1-300 37 1116.73 1.00 0.70-1.42 1.000
Over 300 6 2408.52 2.28 0.75-6.95 0.146
Arsenic (µg/L) Heart disease Rate (per 100,000) Adjusted IRR1 p
0-5 44 300.63 ref ref ref
5.1-20 26 287.4 1.07 0.64-1.78 0.810
20.1-100 72 336.97 1.22 0.82-1.82 0.317
100.1-300 17 513.09 1.55 0.88-2.73 0.125
Over 300 2 802.83 2.47 0.50-12.18 0.265
Arsenic (µg/L) Cancer Rate (per 100,000) Adjusted IRR1 95% CI p
0-5 15 102.49 ref ref ref
5.1-20 14 154.75 1.62 0.79-3.33 0.191
20.1-100 24 112.32 1.13 0.59-2.19 0.708
100.1-300 6 181.09 1.50 0.58-3.85 0.398
Over 300 1 401.42 3.99 0.59-27.17 0.157
Arsenic (µg/L) Stroke Rate (per 100,000) Adjusted IRR1 95% CI p
0-5 53 362.13 ref ref ref
5.1-20 16 176.86 0.47 0.27-0.84 0.010
20.1-100 41 191.89 0.51 0.34-0.79 0.002
100.1-300 7 211.27 0.52 0.25-1.10 0.087
Over 300 1 401.41 1.02 0.16-6.71 0.980
1: Incidence rate ratio adjusted for age, sex education, smoking, alcohol use, farm work
any exposure lag period could reﬂect a shorter lag time between exposure to arsenic and the development
of symptoms related to heart disease. Although we lacked sufﬁcient cases to examine speciﬁc types of
heart disease mortality and speciﬁc cancer mortality, the results we observed are consistent with previous
studies linking cancer and heart disease mortality to arsenic exposure [3, 8, 23].
Thecardiaceffectsofarsenicexposurearewellknownfromacutehighexposuresinoccupational[24]
and medical settings [25], and intentional poisonings [26]. Other epidemiologic studies have observed
associations between ischemic heart disease mortality [3, 8, 23], ischemic heart disease incidence [27],
hypertensive heart disease mortality [28], hypertension [29], vascular disease mortality [30], carotid
atherosclerosis [31], and increased blood pressure [32] and arsenic exposure.
Arsenic in drinking water is an established cause of skin, bladder and lung cancer [33]. Previous epi-
demiologic studies have shown associations with arsenic and elevated mortality from numerous cancers
including and bladder [1, 2, 3],lung [1, 34, 35] and liver, kidney, prostate, stomach as well as other inter-
nal cancers [3, 4, 28, 34, 35, 36]. Our observations generally support these ﬁndings, providing evidence
that after 10-20 years of arsenic exposure, there was an increase in all cancer mortality among residents
of Shahai village related in a dose-response manner to arsenic exposure. The majority of cancers deathsInt. J. Environ. Res. Public Health 2009, 6 1118
Table 5. Poisson regression model results for mortality between January 1, 1997 and De-
cember 1, 2004 and arsenic exposure for all residents of Shahai village.
All subjects
All-cause mortality Heart disease mortality Cancer mortality Stroke mortality
IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p IRR1/95% CI/p
Arsenic
50 µg/L increase 1.02 1.12* 1.07 0.82
0.94,1.11 1.01,1.23 0.89,1.28 0.65,1.03
0.616 0.034 0.464 0.086
Age
1.09*** 1.14*** 1.05*** 1.11***
1.08,1.10 1.12,1.15 1.03,1.07 1.09,1.13
0.000 0.000 0.000 0.000
Sex
(female vs male) 0.83 1.18 0.63 0.85
0.67,1.02 0.86,1.62 0.38,1.07 0.55,1.29
0.073 0.300 0.085 0.440
Education2
1.27** 1.03 1.75** 1.20
1.09,1.49 0.81,1.30 1.20,2.57 0.87,1.66
0.003 0.832 0.004 0.267
Current smoker
(yes vs. no) 1.17 1.33 2.47*** 1.13
0.97,1.42 0.96,1.84 1.53,3.99 0.76,1.68
0.101 0.085 0.000 0.551
Alcohol use
(yes vs. no) 1.15 0.96 1.32 0.97
0.94,1.40 0.67,1.36 0.79,2.20 0.64,1.47
0.178 0.802 0.284 0.882
Farmer
(yes vs. no) 1.27 3.31*** 1.72 1.29
0.93,1.73 1.83,5.98 0.71,4.18 0.74,2.26
0.132 0.000 0.233 0.375
N 12600 12600 12600 12600
1: 1: Incidence rate ratio adjusted for age, sex, education, smoking, drinking, and farm work
* p<0.05, ** p<0.01, *** p<0.001
2: IRR represents the effect of each lower completed education level (1=college, 2-high school, 3=middle school,
4=primary school, 5=less than primary school)
were classiﬁed as lung, stomach, liver and esophagus. We observed only one death due to bladder can-
cer, and one due to skin cancer. Some authors have suggested a latency period between arsenic exposure
and bladder cancer of 30 years or longer [37, 38]. Such a long latency period would make it difﬁcult to
observe an increase in bladder cancer mortality among Shahai residents who have been exposed at most
about 20 years. The single skin cancer death was one of the most highly exposed residents of the villageInt. J. Environ. Res. Public Health 2009, 6 1119
(525.2 µg/L). Because the region is a rural area lacking a systematic method for classifying mortality,
misdiagnoses, misclassiﬁcation, and deaths due to other (competing) causes may also account for the
low rate of bladder cancer mortality, and the misclassiﬁcation of types of cancer mortality. Only 13 of
the 76 cancer deaths were conﬁrmed by pathology.
We cannot explain a decline in stroke mortality among respondents exposed to 5.1-20 µg/L and 20.1-
100 µg/L among those exposed since 1995, but such a negative association between stroke mortality
and arsenic exposure was not supported by the other analyses we conducted and presented. In contrast,
studies of chronically exposed populations in Taiwan [4, 39], observed a positive association between
arsenic exposure and cerebrovascular disease. An earlier study in Taiwan [35] and studies in occupation-
ally exposed cohorts [40, 41] also failed to observe an association between cerebrovascular disease and
arsenic exposure.
Our reliance on self-report and the lack of sophisticated diagnostic facilities may have lead to mis-
classiﬁcation of cause of death, even for the broad categories of death we examined. To account for
this possibility, we examined all-cause mortality, which would be unaffected by such misclassiﬁcation,
and would be accurately recalled by immediate family members. Despite the limitations resulting from
self-report and potential misclassiﬁcation, this study had signiﬁcant strengths. The natural range in ar-
senic exposure in the village allowed us to compare highly exposed and less exposed residents within the
same village for analysis. Different villages, regions, or populations could differ from Shahai village in
numerous ways, resulting in a biased comparison. Unlike studies using a strictly ecological design, we
had access to individual-level information and were able to control for important potential confounding
factors. We were unable to control for some important covariates such as body mass index, diet and
exercise. Although it is not clear how this may have affected our results, as we noted above, residents
from this area are generally in good health and are predominantly from a single ethnic group (Han). A
previous study found a low range of BMI in the region and found no direct association between BMI and
prolonged QT interval [42].
It is unlikely that exposure to other sources of arsenic or other water sources affected our study results.
The vast majority of residents rely solely on their household well for water. This well water is likely the
main source of arsenic exposure in this region. There is no evidence of other major sources of arsenic
exposure, for example, from indoor coal combustion or from pesticide applications.
We assumed that measured arsenic exposure at the water source in 2004 has remained relatively stable
for the past 5, 10, 15 and 20 years. Based on limited data from 57 wells measured for arsenic in 1992
[43], we observed a good correlation to these same wells measured during this study (Pearsons r=0.76,
p<0.0005). If arsenic changed substantially and the change was independently associated with mortality
or morbidity due to other factors, our results may be biased with the direction of the bias difﬁcult to
predict. It seems more likely that any change in arsenic over time would be randomly associated with
future mortality rates and such random misclassiﬁcation would tend to attenuate our results toward no
observable (null) effect. The results we observed would therefore be underestimates of the actual effect
of arsenic on mortality.
We did not observe enough mortality to present a detailed categorical assessment of arsenic or an
analysis of potential threshold effect points, and in the categorical analysis most results failed to achieve
statistical signiﬁcance. Without a large number of cases, valuable information can be lost by catego-Int. J. Environ. Res. Public Health 2009, 6 1120
rization, therefore we rely primarily on the continuous dose-response assessment for our inference and
conclusions. Future studies should attempt to include large numbers of cases so a more detailed categor-
ical, non-linear and threshold analysis can be reliably conducted.
In summary, for the period between January 1, 1997 and December 1, 2004, heart disease mortality
was associated with arsenic levels in well water. Cancer mortality and all-cause mortality were also
associated with arsenic levels in well water among those exposed at least 10-20 years. Cerebrovascu-
lar mortality was not associated with well-water arsenic exposure. This is the ﬁrst study to document
increased arsenic-associated mortality in the Bayingnormen Inner Mongolia region of China.
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